TABLE 2.
β-Lactam(s) | MIC (μg/ml) |
||
---|---|---|---|
P. fluorescens PF-1 | E. coli DH10B (pSauI)a | E. coli DH10B | |
Amoxicillin | >256 | >256 | 4 |
Amoxicillin + CLAb | >256 | 16 | 4 |
Ticarcillin | >256 | >256 | 4 |
Ticarcillin + CLA | >256 | 128 | 4 |
Piperacillin | 4 | 256 | 1 |
Cephalothin | >256 | 128 | 2 |
Cefuroxime | >256 | 16 | 0.5 |
Cefoxitin | >256 | 4 | 1 |
Ceftazidime | 2 | 0.5 | 0.5 |
Cefotaxime | >32 | 0.5 | 0.12 |
Cefepime | >16 | 0.12 | 0.06 |
Moxalactam | >256 | 0.12 | 0.12 |
Aztreonam | >256 | 16 | 0.25 |
Imipenem | >16 | 2 | 0.12 |
Imipenem + CLA | >16 | 0.25 | 0.12 |
Meropenem | >16 | 0.25 | 0.12 |
Ertapenem | >16 | 0.25 | 0.12 |
E. coli DH10B(pSau1) expressed β-lactamase BIC-1 from P. fluorescens PF-1.
CLA, clavulanic acid at a fixed concentration of 4 μg/ml.